• The Magazine
  • Advertising
  • NLS Member
  • About Us
  • Contact
  • Subscribe
  • Sign in
  • Pharma
  • Medtech
  • Biotech
  • Science
  • Events
  • Careers
  • Jobs
  • Opinion & Debate
  • The Magazine
  • Advertising
  • NLS Member
  • About Us
  • Contact
Menu
  • Subscribe
  • Sign in

No 02 2023

QTE Development

-

May 1, 2023

Share article on X
Share article on Linkedin

Updated: January 31, 2025, 09:21 am

Published: May 1, 2023

Top stories

In a new job – August 25, 2026

ALK-Abelló appoints new head of Global R&D

ALK-Abelló has appointed Jacob Glenting as Executive Vice President and head of Global R&D, effective 1 September.

Pharma Business – August 25, 2026

FDA proposes reclassifying Photocure’s blue light cystoscopy systems

The US FDA has proposed reclassifying blue light cystoscopy (BLC) systems used with Photocure’s imaging agent Cysview for bladder cancer detection from Class III to Class II, a move the Norwegian medtech company says will support wider adoption of the technology in US hospitals.

New Market – August 24, 2026

Genetic Analysis enters Australian market

Norwegian microbiome diagnostics company Genetic Analysis has placed its GA-map Dysbiosis Test at the Centre for Digestive Diseases (CDD) in Sydney – the company’s first placement in Australia and a new milestone in its international expansion.

Biotech Business – August 24, 2026

Nykode secures new US patent for cancer vaccine candidate

Nykode Therapeutics has been granted a new US patent covering its individualized neoantigen cancer vaccine VB10.NEO and related modular vaccine designs, strengthening the company’s intellectual property position as the neoantigen vaccine field gains momentum.

Follow NLS news
Follow us on XFollow us on LinkedinFollow us on Bluesky

Related posts

In a new job - August 25, 2026

ALK-Abelló appoints new head of Global R&D

ALK-Abelló has appointed Jacob Glenting as Executive Vice President and head of Global R&D, effective 1 September.

Pharma Business - August 25, 2026

FDA proposes reclassifying Photocure’s blue light cystoscopy systems

The US FDA has proposed reclassifying blue light cystoscopy (BLC) systems used with Photocure's imaging agent Cysview for bladder cancer detection from Class III to Class II, a move the Norwegian medtech company says will support wider adoption of the technology in US hospitals.

New Market - August 24, 2026

Genetic Analysis enters Australian market

Norwegian microbiome diagnostics company Genetic Analysis has placed its GA-map Dysbiosis Test at the Centre for Digestive Diseases (CDD) in Sydney – the company's first placement in Australia and a new milestone in its international expansion.

Biotech Business - August 24, 2026

Nykode secures new US patent for cancer vaccine candidate

Nykode Therapeutics has been granted a new US patent covering its individualized neoantigen cancer vaccine VB10.NEO and related modular vaccine designs, strengthening the company's intellectual property position as the neoantigen vaccine field gains momentum.

Pharma Business - August 24, 2026

Bavarian Nordic raises full-year 2026 guidance

Bavarian Nordic has upgraded its financial guidance for 2026, now expecting total revenue of approximately DKK 5,700 million and an EBITDA margin of around 30 percent, on the back of continued strength in its Public Preparedness business. The Danish vaccine maker is also launching a new share buyback programme of up to DKK 750 million.

Clinical Trials - August 24, 2026

Elicera Therapeutics reports 91% response rate in CAR T study

Elicera Therapeutics has reported continued strong results from its Phase I/IIa CARMA study of ELC-301 in relapsed or refractory B-cell lymphoma, with an overall response rate of 91 percent and disease control in all evaluable patients.

Biotech Business - August 21, 2026

Hansa Biopharma prepares for US listing

The company has announced confidential submission of draft registration statement to the SEC to allow for a potential listing of ADSs in the United States.

Sign up to our newsletter: Nordic Life Science News!

I confirm that I want to subscribe to newsletters from Nordic Life Science and that Nordic Life Science has the right to save my email address. Read our privacy policy here

Read the latest issue!

Sign up for a subscription and read our latest digital issue today.

Sign up
Sign up

The leading life science news channel in the Nordic region.

© NLS Media Group AB – All rights reserved

Digital and print
  • The magazine
  • Subscribe
  • Newsletter
More information
  • About us
  • Contact
  • Advertising
Social media
  • LinkedIn
  • Bluesky
  • X
NLS Media Group AB

St Paulsgatan 13

118 46 Sweden

info@nlsnews.com

+46-8-588 941 51

  • Cookies
  • Data management and privacy policy

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.